Product NDC: | 0517-7504 |
Proprietary Name: | Acetylcysteine |
Non Proprietary Name: | acetylcysteine |
Active Ingredient(s): | 100 mg/mL & nbsp; acetylcysteine |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | INHALANT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0517-7504 |
Labeler Name: | American Regent, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA072489 |
Marketing Category: | ANDA |
Start Marketing Date: | 19951001 |
Package NDC: | 0517-7504-25 |
Package Description: | 25 VIAL, GLASS in 1 TRAY (0517-7504-25) > 4 mL in 1 VIAL, GLASS |
NDC Code | 0517-7504-25 |
Proprietary Name | Acetylcysteine |
Package Description | 25 VIAL, GLASS in 1 TRAY (0517-7504-25) > 4 mL in 1 VIAL, GLASS |
Product NDC | 0517-7504 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | acetylcysteine |
Dosage Form Name | INHALANT |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 19951001 |
Marketing Category Name | ANDA |
Labeler Name | American Regent, Inc. |
Substance Name | ACETYLCYSTEINE |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Antidote [EPC],Antidote for Acetaminophen Overdose [EPC],Decreased Respiratory Secretion Viscosity [PE],Increased Glutathione Concentration [PE],Mucolytic [EPC],Reduction Activity [MoA] |